echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Infection > NEJM: therapeutic effect of different antiviral agents on the Omicron subvariant BA.2.75

    NEJM: therapeutic effect of different antiviral agents on the Omicron subvariant BA.2.75

    • Last Update: 2022-10-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The five sublines of the B.


    It is also worth noting that the antigenicity of BA.


    To assess the efficacy of authorized therapeutic monoclonal antibodies against BA.


    Table 1 Efficacy of monoclonal antibodies and antiviral drugs on in vitro Omicron subvariants

    REGN10987 (sold as imdevimab) loses its neutralizing activity on BA.


    Remdesivir is an RNA-dependent RNA polymerase inhibitor of SARS-CoV-2 that has been approved by the FDA for the treatment of coronavirus disease


    BA.


    Thus, our data suggest that remdesivir, molnupiravir and nirmatrelvir may be effective against BA.


    Original Source:

    Efficacy of Antiviral Agents against the Omicron Subvariant BA.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.